Have you checked out our newsletter?
Stay ahead with expert insights, strategic tips, and industry trends—all designed to boost your brand's med comm initiatives.
"*" indicates required fields
Get fresh insights and candid perspectives on timely issues impacting the pharmaceutical industry from our blog.
The Latest News
Will Your Launch Strategy Succeed or Fail?
The Challenge: A Faster, More Complex Launch Environment In today’s pharmaceutical market, strong science is the foundation, but it doesn’t always guarantee a successful launch. Many of us have experienced a disappointing launch when everything we anticipated pointed to success. Today, launches are more complex than they were a decade
HEAR to Reduce Conflict Between Key Opinion Leaders – Dan Recommends
Disagreements are common among healthcare professionals, but when they turn into conflict, it can be very challenging to manage strong personalities who take a hard opposing stance to another person. It is clear to all of us when communicating medical or scientific information, experts sometimes naively believe that their own
Case Study: KOL Identification in Late-Stage Clinical Trials
A BioPharma client had an orphan drug used to treat a rare endocrine disorder in late-stage clinical trials, but no existing network of Key Opinion Leaders (KOLs)…
When and Why Simple Might Be Better for KOL Identification & Mapping
Identifying and mapping the right Key Opinion Leaders (KOLs) is the foundational tactic that lays the groundwork for your peer-to-peer strategies that follow, whether conducting advisory boards or building a speaker’s bureau. KOLs are critical to educating healthcare practitioners (HCPs) who will ultimately deliver your product to the patients who
How to Keep Advisory Boards Simple – Dan Recommends
When done right, advisory boards are exhilarating. We often gain insights and new ways of thinking from key opinion leaders (KOLs) that we likely never considered. In the hundreds of advisory boards I’ve been a part of through the years, I’ve been able to watch the greatest minds present complex
Trust is a Two-Way Street
Recent news headlines have spotlighted how unethical and irresponsible behavior on the part of pharma companies and their agencies can breach public trust…
I’m Grateful for the Little Liar – Dan Recommends – January 2024
In the last “Dan Recommends,” I wrote about how gratitude unlocks the best qualities in each of us. When we show gratitude, it makes us a better person. Research has shown that it improves our sleep, our generosity, our health, and our relationships. I suggest writing a letter to someone
7 Steps to Planning High-Impact Advisory Boards
Advisory boards are a critical component to a successful pharma market–shaping strategy. They provide a window into the minds of top key opinion leaders (KOLs) to gain valuable insights on products, clinical studies, competition, or market dynamics. At the heart of a successful advisory board is a planning team that
Pharma Trends – January 2024
A patient-centric approach is becoming increasingly important trend in pharma marketing. While this concept isn’t new, ways to leverage it across the brand lifecycle – from clinical research to commercialization – are continuously evolving. Check out these resources on the top pharma trends in January 2024: Source: pharmaphorum Author:Steve Rosenberg Patient